These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30871232)

  • 1. ADRB2-Targeting Therapies for Prostate Cancer.
    Kulik G
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of ADRB2/PKA Signaling Pathway Facilitates Lipid Synthesis in Meibocytes, and Beta-Blocker Glaucoma Drug Impedes PKA-Induced Lipid Synthesis by Inhibiting ADRB2.
    Jun I; Choi YJ; Kim BR; Seo KY; Kim TI
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of signaling downstream of beta-2 adrenoceptor by propranolol in prostate cancer cells.
    Alaskar A; Abdulraqeb Ali A; Hassan S; Shinwari Z; Alaiya A; von Holzen U; Miller L; Kulik G
    Prostate; 2023 Feb; 83(3):237-245. PubMed ID: 36373761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral stress accelerates prostate cancer development in mice.
    Hassan S; Karpova Y; Baiz D; Yancey D; Pullikuth A; Flores A; Register T; Cline JM; D'Agostino R; Danial N; Datta SR; Kulik G
    J Clin Invest; 2013 Feb; 123(2):874-86. PubMed ID: 23348742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1.
    Hassan S; Pullikuth A; Nelson KC; Flores A; Karpova Y; Baiz D; Zhu S; Sui G; Huang Y; Choi YA; D'Agostino R; Hemal A; von Holzen U; Debinski W; Kulik G
    Mol Cancer Res; 2020 Dec; 18(12):1839-1848. PubMed ID: 32928910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms.
    Xie WY; He RH; Zhang J; He YJ; Wan Z; Zhou CF; Tang YJ; Li Z; Mcleod HL; Liu J
    Oncol Rep; 2019 Jan; 41(1):341-350. PubMed ID: 30542705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The β
    Braadland PR; Ramberg H; Grytli HH; Urbanucci A; Nielsen HK; Guldvik IJ; Engedal A; Ketola K; Wang W; Svindland A; Mills IG; Bjartell A; Taskén KA
    Mol Cancer Res; 2019 Nov; 17(11):2154-2168. PubMed ID: 31395667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β2.
    Long Q; Liu X; Qi Q; Guo SW
    Hum Reprod; 2016 Nov; 31(11):2506-2519. PubMed ID: 27664956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.
    Lehrer S; Rheinstein PH
    Discov Med; 2020; 30(161):163-171. PubMed ID: 33593484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer.
    Kwon DH; Zhang L; Quigley DA; Foye A; Chen WS; Wong CK; Feng FY; Bailey A; Huang J; Stuart JM; Friedl V; Weinstein AS; Beer TM; Alumkal JJ; Rettig M; Gleave M; Lara PN; Thomas GV; Li P; Lui A; Small EJ; Aggarwal RR
    Urol Oncol; 2020 Dec; 38(12):931.e9-931.e16. PubMed ID: 32624423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors.
    Xu Y; Wang J; Wang X; Zhou X; Tang J; Jie X; Yang X; Rao X; Xu Y; Xing B; Li Z; Wu G
    Cell Death Discov; 2022 Jan; 8(1):36. PubMed ID: 35075132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2.
    Zhang X; Zhang Y; He Z; Yin K; Li B; Zhang L; Xu Z
    Cell Death Dis; 2019 Oct; 10(11):788. PubMed ID: 31624248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
    Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways.
    Özler S; Pazarci P
    Anticancer Drugs; 2022 Apr; 33(4):384-388. PubMed ID: 35266887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
    Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
    Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of human hepatocellular carcinoma cells by antagonism of the β
    Dang D; Zhang J; Yang J
    Oncol Lett; 2018 Aug; 16(2):1425-1430. PubMed ID: 30008820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-3 protects diabetic hearts from acute myocardial infarction/reperfusion injury through β2AR, cAMP/PKA, and BDNF/TrkB signaling pathways.
    Gong J; Zhou F; Wang SXX; Xu J; Xiao F
    Aging (Albany NY); 2020 Jul; 12(14):14300-14313. PubMed ID: 32692723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.
    Wu FQ; Fang T; Yu LX; Lv GS; Lv HW; Liang D; Li T; Wang CZ; Tan YX; Ding J; Chen Y; Tang L; Guo LN; Tang SH; Yang W; Wang HY
    J Hepatol; 2016 Aug; 65(2):314-24. PubMed ID: 27154061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of β2-adrenergic Receptor Ameliorates Amyloid-β-induced Mitophagy Defects and Tau Pathology in Mice.
    Chai GS; Wu JJ; Gong J; Zhou JL; Jiang ZQ; Yi HY; Gu Y; Huang HH; Yao ZY; Zhang YQ; Zhao P; Nie YJ
    Neuroscience; 2022 Nov; 505():34-50. PubMed ID: 36208707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.
    Braadland PR; Grytli HH; Ramberg H; Katz B; Kellman R; Gauthier-Landry L; Fazli L; Krobert KA; Wang W; Levy FO; Bjartell A; Berge V; Rennie PS; Mellgren G; Mælandsmo GM; Svindland A; Barbier O; Taskén KA
    Oncotarget; 2016 Jan; 7(2):1878-94. PubMed ID: 26646591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.